主动吸烟的间歇性跛行患者下肢旁路术后的长期结局
基于血管质量倡议数据库2003至2019年数据,对因间歇性跛行行择期下肢旁路术的609例从不吸烟者、3388例既往吸烟者和2123例当前吸烟者进行倾向性评分匹配分析。结果显示既往吸烟者与从不吸烟者5年总生存、保肢、免于再干预和无截肢生存均无差异;既往吸烟者较当前吸烟者总生存和无截肢生存更优。
要点
- 既往吸烟者与从不吸烟者5年总生存、保肢、免于再干预和无截肢生存均无显著差异。
- 既往吸烟者较当前吸烟者5年总生存更优(HR 1.37)。
- 既往吸烟者较当前吸烟者5年无截肢生存更优(HR 1.38)。
核心结论
- 既往吸烟者较当前吸烟者5年总生存和无截肢生存更优,且既往吸烟者在5年总生存、保肢、免于再干预和无截肢生存方面与从不吸烟者相似。
- 作者认为结构化戒烟应成为间歇性跛行患者择期下肢旁路术前血管门诊就诊的更突出部分。
研究设计与样本
- 查询血管质量倡议血管植入物监测和介入结局网络下肢旁路数据库2003至2019年数据。
- 纳入因间歇性跛行行下肢旁路术的609例(10.0%)从不吸烟者、3388例(55.3%)既往吸烟者和2123例(34.7%)当前吸烟者。
- 对36项临床变量进行两次不放回倾向性评分匹配:既往吸烟者与从不吸烟者匹配,当前吸烟者与既往吸烟者匹配。
- 主要结局包括5年总生存、保肢、免于再干预和无截肢生存。
主要发现
- 既往吸烟者与从不吸烟者匹配后得到497对匹配良好的配对,总生存无差异(HR 0.93,95%CI 0.70-1.24,P=0.61),保肢无差异(HR 1.07,95%CI 0.63-1.82,P=0.80),免于再干预无差异(HR 0.9,95%CI 0.71-1.21,P=0.59),无截肢生存无差异(HR 0.93,95%CI 0.71-1.22,P=0.62)。
- 当前吸烟者与既往吸烟者匹配后得到1451对匹配良好的配对,保肢无差异(HR 1.36,95%CI 0.94-1.97,P=0.11),免于再干预无差异(HR 1.02,95%CI 0.88-1.19,P=0.76)。
- 既往吸烟者较当前吸烟者总生存显著增高(HR 1.37,95%CI 1.15-1.64,P<0.001),无截肢生存显著增高(HR 1.38,95%CI 1.18-1.62,P<0.001)。
临床怎么用
- 作者认为结构化戒烟应成为间歇性跛行患者择期下肢旁路术前血管门诊就诊的更突出部分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Smoking is known to increase complications, including poor wound healing, coagulation abnormalities, and cardiac and pulmonary ramifications. Across specialties, elective surgical procedures are commonly denied to active smokers. Given the base population of active smokers with vascular disease, smoking cessation is encouraged but is not required the way it is for elective general surgery procedures. We aim to study the outcomes of elective lower extremity bypass (LEB) in actively smoking claudicants. METHODS: We queried the Vascular Quality Initiative Vascular Implant Surveillance and Interventional Outcomes Network LEB database from 2003 to 2019. In this database we found 609 (10.0%) never smokers (NS), 3388 (55.3%) former smokers (FS), and 2123 (34.7%) current smokers (CS) who underwent LEB for claudication. We performed two separate propensity score matches without replacement on 36 clinical variables (age, gender, race, ethnicity, obesity, insurance, hypertension, diabetes, coronary artery disease, congestive heart failure, chronic obstructive pulmonary disease, chronic kidney disease, previous coronary artery bypass graft, carotid endarterectomy, major amputation, inflow treatment, preoperative medications and treatment type), one of FS to NS and a second analysis of CS to FS. Primary outcomes included 5-year overall survival (OS), limb salvage (LS), freedom from reintervention (FR), and amputation-free survival (AFS). RESULTS: Propensity score matches resulted in 497 well-matched pairs of NS and FS. In this analysis we found no difference in terms of OS (HR, 0.93; 95% CI, 0.70-1.24; P = .61), LS (HR, 1.07; 95% CI, 0.63-1.82; P = .80), FR (HR, 0.9; 95% CI,0.71-1.21; P = .59), or AFS (HR, 0.93; 95% CI,0.71-1.22; P = .62). In the second analysis, we had 1451 well-matched pairs of CS and FS. There was no difference in LS (HR, 1.36; 95% CI,0.94-1.97; P = .11) or FR (HR, 1.02; 95% CI,0.88-1.19; P = .76). However, we did find a significant increase in OS (HR, 1.37; 95% CI,1.15-1.64, P <.001) and AFS (HR, 1.38; 95% CI,1.18-1.62; P < .001) in FS compared with CS. CONCLUSIONS: Claudicants represent a unique nonemergent vascular patient population that may require LEB. Our study found that FS have better OS and AFS when compared with CS. Additionally, FS mimic nonsmokers at 5-year outcomes for OS, LS, FR, and AFS. Therefore, structured smoking cessation should be a more prominent part of vascular office visits before elective LEB procedures in claudicants.
引用
- Patel RJ, Zarrintan S, Jagadeesh V, et al. Long-term outcomes after lower extremity bypass in the actively smoking claudicant. J Vasc Surg. 2023. PMID: 37327952. doi:10.1016/j.jvs.2023.05.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。